Results 41 to 50 of about 5,080,573 (227)

Multiple lymphomatous polyposis: A presentation for mantle cell lymphoma

Clinical Case Reports, 2020
Multiple lymphomatous polyposis is an uncommon presentation of mantle cell lymphoma, and when exhibited should prompt clinicians to incorporate mantle cell lymphoma into their differential workup.
Cory Gallivan, Ali Akbar
doaj   +1 more source

Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma

Heliyon, 2019
IFI16, member of the IFN-inducible PYHIN-200 gene family, modulates proliferation, survival and differentiation of different cell lineages. In particular, IFI16 expression, which is regulated during the differentiation of B cells, was recently studied in
Pier Paolo Piccaluga, Mohsen Navari, Axel Visani, Flavia Rigotti, Claudio Agostinelli, Simona Righi, Erica Diani, Marco Ligozzi, Maria Carelli, Cristina Ponti, Isabella Bon, Donato Zipeto, Santo Landolfo, Davide Gibellini   +13 more
doaj   +1 more source

Discovery of novel molecular and biochemical predictors of response and outcome in diffuse large B-cell lymphoma [PDF]

, 2009
PhDDiscovery of Novel Molecular and Biochemical Predictors of Response and Outcome in Diffuse Large B-cell Lymphoma Diffuse large B-cell lymphoma (DLBCL) is the commonest form of non-Hodgkin lymphoma and responds to treatment with a 5-year overall ...
Last, Kim William
core   +4 more sources

A Rare Case of Severe Lactic Acidosis in a Patient With Mantle Cell Lymphoma

Journal of Investigative Medicine High Impact Case Reports, 2021
Lactic acidosis is an extremely rare paraneoplastic manifestation of hematological malignancies, and often carries an extremely poor prognosis. Mantle cell lymphoma is an aggressive and rare form of non-Hodgkin lymphoma.
Kok Hoe Chan MD, Laxminarayan Prabhakar MD, Omar Al-Radideh MD, Byron Okwesili MD, Gowthami Are MD, Hamid Shaaban MD   +5 more
doaj   +1 more source

CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma [PDF]

, 2022
CD24 and its ligand Siglec-10 were described as an innate immune checkpoint in carcinoma. Here, we investigated this axis in B-cell lymphoma by assessing CD24 expression and evaluating pro-phagocytic effects of CD24 antibody treatment in comparison to ...
Edwin Bremer, Freile, Jimena Álvarez, Harm Jan Lourens, Freile, Jimena Álvarez; id_orcid, Macarena González Corrales, Huls, Gerwin, Cendrowicz, Ewa, Ustyanovska Avtenyuk, Natasha, van Meerten, Tom, Bremer, Edwin, Jimena Álvarez Freile, Ewa Cendrowicz, Natasha Ustyanovska Avtenyuk, Lourens, Harm Jan, Bremer, Edwin; id_orcid, Ustyanovska Avtenyuk, Natasha; id_orcid, Gerwin Huls, Tom van Meerten, Corrales, Macarena González   +18 more
core   +2 more sources

Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion

Case Reports in Hematology, 2020
Mantle cell lymphoma is a non-Hodgkin lymphoproliferative neoplasm with several clinical and morphologic variants linked, primarily, through genetic derangement of the cyclin D1 locus.
Robert K. McCall, Changlee S. Pang, Mark J. Pettenati   +2 more
doaj   +1 more source

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma. [PDF]

PLoS ONE, 2012
Mantle cell lymphoma is characterized by a genetic translocation results in aberrant overexpression of the CCND1 gene, which encodes cyclin D1. This protein functions as a regulator of the cell cycle progression, hence is considered to play an important ...
Shiri Weinstein, Rafi Emmanuel, Ashley M Jacobi, Avigdor Abraham, Mark A Behlke, Andrew G Sprague, Tatiana I Novobrantseva, Arnon Nagler, Dan Peer   +8 more
doaj   +1 more source

Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions – case report and review of literature

World Journal of Surgical Oncology, 2009
Background Mantle cell lymphoma (MCL) is an aggressive type of B-cell non-Hodgkin's lymphoma that originates from small to medium sized lymphocytes located in the mantle zone of the lymph node. Extra nodal involvement is present in the majority of cases,
Abo Stephen M, Cosgrove John M, Reed Mary, Parikh Nalini S, Constantine Radu, Kella Venkata KN, King Saundra   +6 more
doaj   +1 more source

Using cell‐free RNA to identify B‐ and T‐cell clonality for diagnosis and monitoring of B‐ and T‐cell neoplasms

FEBS Open Bio, EarlyView.
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar, Sally Agersborg, Ahmed Charifa, Pooja Phull, Noa Biran, David Vesole, Harsh Parmar, Andrew Pecora, Andrew Ip, Andre Goy, David Siegel, Maher Albitar   +11 more
wiley   +1 more source

O‐GlcNAcylation Regulation of SNAP29‐Dependent Autophagy Activation Dictates Chemoresistance in Gastric Cancer

Advanced Science, EarlyView.
Model illustrating the proposed mechanism by which chemotherapy‐induced downregulation of OGT disrupts SNAP29 O‐GlcNAcylation, promoting STX17‐SNAP29‐VAMP8 SNARE complex assembly and protective autophagy, leading to chemoresistance, which in turn establishes a feedforward loop to perpetuate drug tolerance.
Liang Tang, Shaoji Zhao, Ziling Shao, Tao Luo, Baifu Peng, Yifan Liu, Jinning Ye, Jianjun Peng, Kaiyu Sun, Jianbo Xu   +9 more
wiley   +1 more source